SG Americas Securities
PRTK

SG Americas Securities’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

SG Americas Securities’s Portfolio PRTK Stock Details PRTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-13,419
Closed -$26K – 3665
2022
Q2 		$26K Buy
+13,419
New +$29.3K ﹤0.01% 3328
2022
Q1 		– Sell
-19,274
Closed -$87K – 3589
2021
Q4 		$87K Sell
19,274
-12,471
-39% -$59.2K ﹤0.01% 3114
2021
Q3 		$154K Buy
+31,745
New +$175K ﹤0.01% 3417
2020
Q3 		– Sell
-23,146
Closed -$121K – 3646
2020
Q2 		$121K Buy
+23,146
New +$103K ﹤0.01% 3244
2017
Q4 		– Sell
-4,908
Closed -$123K – 3747
2017
Q3 		$123K Buy
+4,908
New +$114K ﹤0.01% 3034
2017
Q1 		– Sell
-8,737
Closed -$135K – 3625
2016
Q4 		$135K Buy
+8,737
New +$113K ﹤0.01% 2656
2015
Q4 		– Sell
-5,674
Closed -$108K – 3051
2015
Q3 		$108K Buy
+5,674
New +$141K ﹤0.01% 1835
2015
Q1 		– Sell
-31,810
Closed -$1.23M – 3162
2014
Q4 		$1.23M Buy
31,810
+24,585
+340% +$587K 0.01% 1150
2014
Q3 		$176K Sell
7,225
-904
-11% -$23.6K ﹤0.01% 2047
2014
Q2 		$194K Buy
8,129
+3,850
+90% +$126K ﹤0.01% 2041
2014
Q1 		$158K Buy
4,279
+1,777
+71% +$70.2K ﹤0.01% 2033
2013
Q4 		$101K Buy
+2,502
New +$106K ﹤0.01% 2405

Other funds holding PRTK

ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
GAI
General American Investors New York $1.52B AUM 37.94% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
BC
Bruce & Co Chicago, Illinois $350M AUM 33.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
1CM
1492 Capital Management Milwaukee, Wisconsin $263M AUM 61.9% 1-Year Est. Return

SG Americas Securities's PRTK Position: Q3 2022 in Review

SG Americas Securities sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q3 2022, closing a stake of 13,419 shares — an estimated $26K sold.

SG Americas Securities first reported a position in PRTK in Q4 2013 and held it in 12 quarters. The position peaked at $1.23M in Q4 2014. 72 funds tracked by Wall St. Rank hold PRTK as of Q3 2022.

  • SG Americas Securities reported no remaining Paratek Pharmaceuticals, Inc. position as of Q3 2022 after selling out during the quarter.
  • SG Americas Securities sold 13,419 Paratek Pharmaceuticals, Inc. shares in Q3 2022, an estimated $26K.
  • SG Americas Securities first reported a position in Paratek Pharmaceuticals, Inc. in Q4 2013 and held it in 12 quarters.
  • SG Americas Securities's Paratek Pharmaceuticals, Inc. position peaked at $1.23M in Q4 2014.
  • 72 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q3 2022.

Based on SG Americas Securities's 13F filing for Q3 2022, filed 31 Oct 2022.